Skip to content

Ferring Pharmaceuticals

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile5 entries

  1. 2022

    Scrutiny of Frederik Paulsen’s Russia relationship

    Frederik Paulsen’s former position as Russia’s honorary consul in Lausanne, his contacts with Russian officials, and politically connected travel prompted public criticism and questions examined by Swiss authorities.

  2. 2020

    Desmopressin nasal-spray recall

    The UK Medicines and Healthcare products Regulatory Agency highlighted a recall of all Ferring desmopressin nasal sprays.

  3. 2015

    Bravelle recall and subsequent litigation

    Ferring recalled Bravelle after testing suggested that product potency could be lower than stated. A class action was filed in 2016, alleging risks to women using the fertility treatment.

  4. Product-promotion and advertising scrutiny

    Ferring was criticized or accused in public and regulatory material of presenting misleading information about products including desmopressin and Glypressin. A Pentasa advertisement in a UK journal was also reported as non-compliant with publication regulations.

  5. VSL#3 formulation and trademark dispute

    Ferring has faced legal proceedings brought by Professor Claudio De Simone concerning the continued distribution and labeling of a product marketed as VSL#3 after their earlier relationship ended and the formulation changed.